Hypertension may increase risk for late-onset epilepsy
Nov 17, 2021
After adjustment for prevalent and interim stroke, the risk for developing epilepsy increased almost twofold.
Pfizer asks FDA for emergency approval of its COVID-19 antiviral pill
Nov 16, 2021
The request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.
Pricey Alzheimer drug drives spike in Medicare B premium: Officials
Nov 15, 2021
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Ambient temperatures linked to hospitalization for renal diseases
Nov 12, 2021
Ambient temperature is associated with hospitalization for renal diseases, with more prominent risk seen for women, the elderly aged 80 years or older and children aged 0 to 4 years, according to a study...
ASN: Chlorthalidone aids BP control in patients with CKD and HTN
Nov 12, 2021
For patients with stage 4 chronic kidney disease and poorly controlled hypertension, the addition of low dose of chlorthalidone improves blood pressure control.
Sleep onset timing linked to risk of developing CVD
Nov 09, 2021
The lowest cardiovascular disease incidence was seen in association with a sleep-onset time of 10:00 p.m. to 10:59 p.m.
Pfizer set to ask FDA to approve booster for those 18 and older
Nov 09, 2021
Peter Chin-Hong, M.D., an infectious-disease physician at the University of California, San Francisco, said there is “some value” in young people getting a booster to protect older relatives...
Adults with IBD show antibody response to mRNA COVID-19 vaccine
Nov 09, 2021
After mRNA COVID-19 vaccination, 99% of patients with inflammatory bowel disease had detectable antibodies regardless of immunocompromising therapies.
App-based protocol ID’s delirium in hospitalized adults
Nov 08, 2021
Overall accuracy of two-step protocol including two-item screen and 3-minute diagnostic assessment was 89%, 87% for nurses, doctors.